Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer Care in Resource-Limited Countries: Jordan as an Example.
Abdel-Razeq H, Al-Ibraheem A, Al-Rabi K, Shamiah O, Al-Husaini M, Mansour A. Abdel-Razeq H, et al. Among authors: al rabi k. JCO Glob Oncol. 2024 Sep;10:e2400237. doi: 10.1200/GO.24.00237. Epub 2024 Oct 3. JCO Glob Oncol. 2024. PMID: 39361906 Review.
The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis.
Al-Ibraheem A, Abdlkadir AS, Al-Adhami DA, Sathekge M, Bom HH, Ma'koseh M, Mansour A, Abdel-Razeq H, Al-Rabi K, Estrada-Lobato E, Al-Hussaini M, Matalka I, Abdel Rahman Z, Fanti S. Al-Ibraheem A, et al. Among authors: al rabi k. Front Immunol. 2024 Sep 2;15:1424269. doi: 10.3389/fimmu.2024.1424269. eCollection 2024. Front Immunol. 2024. PMID: 39286245 Free PMC article.
Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults.
Al-Rabi K, Ma'koseh M, Al-Qadi F, Hanoon AA, Da'na W, Asha AJ, Abdel Rahman Z, Marie L, Shahin O, Ma'koseh R, Al-Ibraheem A, Zayed A, Yaseen A, Al-Rabee S, Farfoura H, Abdel-Razeq H. Al-Rabi K, et al. Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):715-723. doi: 10.1016/j.clml.2024.05.016. Epub 2024 May 25. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38918115
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan.
Abu Hejleh T, AlSawalha K, Abdel Hafiz S, Al-Batsh T, Abu Hejleh R, Yaser S, Abu Jazar H, Khader J, Alnsour A, Mohamad I, Abdel Jalil R, Abu-Shanab A, Gharaibeh A, Abu Shattal M, Alibraheem A, Haddad H, Mahmoud N, Obeidat S, Al-Jaghbeer MJ, Furqan M, Cortellini A, Velcheti V, Al-Rabi K. Abu Hejleh T, et al. Among authors: al rabi k. Front Oncol. 2024 Apr 30;14:1369126. doi: 10.3389/fonc.2024.1369126. eCollection 2024. Front Oncol. 2024. PMID: 38746680 Free PMC article.
PET/CT in leukemia: utility and future directions.
Al-Ibraheem A, Allouzi S, Abdlkadir AS, Mikhail-Lette M, Al-Rabi K, Ma'koseh M, Knoll P, Abdelrhman Z, Shahin O, Juweid ME, Paez D, Lopci E. Al-Ibraheem A, et al. Among authors: al rabi k. Nucl Med Commun. 2024 Jul 1;45(7):550-563. doi: 10.1097/MNM.0000000000001846. Epub 2024 Apr 22. Nucl Med Commun. 2024. PMID: 38646840 Review.
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.
Remon J, Besse B, Aix SP, Callejo A, Al-Rabi K, Bernabe R, Greillier L, Majem M, Reguart N, Monnet I, Cousin S, Garrido P, Robinet G, Campelo RG, Madroszyk A, Mazières J, Curcio H, Wasąg B, Pretzenbacher Y, Grillet F, Dingemans AC, Dziadziuszko R. Remon J, et al. Among authors: al rabi k. J Clin Oncol. 2024 Apr 20;42(12):1350-1356. doi: 10.1200/JCO.23.01521. Epub 2024 Feb 7. J Clin Oncol. 2024. PMID: 38324744
19 results